-
Uncategorized1 week ago
BeOne commits $300M to US manufacturing expansion, creating 120 new jobs
The addition of small molecule capacity at BeOne Medicines’ Hopewell site will support the company’s hematology efforts and bring total investment in the campus to more...
-
Uncategorized1 week agoVote on key federal health nominee delayed amid questions over vaccine views
WASHINGTON — A Trump administration nominee to lead an agency focused on public health disasters had his confirmation vote postponed amid a lack of support just...
-
Uncategorized1 week agoFrom monolayer to microtissue: Measuring what matters in 3D drug discovery
Darren Heywood, Senior Product Manager at Promega UK, examines assay formats built specifically for 3D measurements. A 3D microtissue, such as a spheroid or organoid, is not...
-
Uncategorized1 week agoSTAT+: HHS to convene experts on standards for clinical AI
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
Uncategorized1 week ago
Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 data
With weight loss topping 20% at 80 weeks in the Phase 3 TRIUMPH-2 and TRIUMPH-3 trials, Eli Lilly plans to file for retatrutide’s approval in the...
-
Uncategorized1 week ago
Roche’s late stage pipeline ‘so full,’ CEO Schinecker not feeling pressure to add on
Roche has 19 investigational medicines that could launch by 2030—and even if not all of them make it to market, the company is “well set-up for...
-
Uncategorized1 week ago
Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides
Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides
-
Uncategorized1 week ago
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
Jideytro is GSK’s first approved product for lung cancer. With its takeover of Nuvalent Bio last month and a deal with Hansoh Pharmaceutical in 2023, the...
-
Uncategorized1 week agoExpect a clash at today’s FDA peptide panel
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. We’re almost through the week. But...
-
Uncategorized1 week agoSTAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
Eli Lilly reported more results Thursday showing that its next-generation obesity drug is highly efficacious at weight loss, but the data from the study, focused on...
